Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-FR
Language English French
Date Updated 2023-02-15 2022-10-25
Drug Identification Number 02298643 02298643
Brand name SANDOZ LEVOFLOXACIN SANDOZ LEVOFLOXACIN
Common or Proper name LEVOFLOXACIN LEVOFLOXACIN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients LEVOFLOXACIN LEVOFLOXACIN
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100FCT 100FCT
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-10-25 2022-10-25
Estimated end date 2023-02-03 2023-02-03
Actual end date 2023-02-14
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Limited inventory has been allocated. Limited inventory has been allocated.
Health Canada comments